Cleared Traditional

K202339 - Molekule Air Mini, Molekule Air Mini + (FDA 510(k) Clearance)

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K202339 · Molekule, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2021
Decision
190d
Days
Class 2
Risk

K202339 is an FDA 510(k) clearance for the Molekule Air Mini, Molekule Air Mini +. Classified as Purifier, Air, Ultraviolet, Medical (product code FRA), Class II - Special Controls.

Submitted by Molekule, Inc. (San Francisco, US). The FDA issued a Cleared decision on February 23, 2021 after a review of 190 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6500 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Molekule, Inc. devices

Submission Details

510(k) Number K202339 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 17, 2020
Decision Date February 23, 2021
Days to Decision 190 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d slower than avg
Panel avg: 128d · This submission: 190d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FRA Purifier, Air, Ultraviolet, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.6500
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Hyman, Phelps & McNamara, P.C.
Adrienne R. Lenz

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FRA Purifier, Air, Ultraviolet, Medical

All 35
Devices cleared under the same product code (FRA) and FDA review panel - the closest regulatory comparables to K202339.
Zener® (model ZEN-001-B1)
K252128 · Uvx, Inc. · Sep 2025
ViroZap Indoor Air Purifier, In Duct Model 1008
K241140 · Applied Photonix, LLC · Aug 2024
AirKEE T900
K232642 · Healkee Medical Pte, Ltd. · May 2024
AirKEE P900
K232933 · Healkee Medical Pte, Ltd. · May 2024
Airgle Room Air Purifier
K232645 · Airgle Corporation · Feb 2024
Synexis Sphere Rx
K221540 · Synexis, LLC · Jun 2023